These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 22168273

  • 1. Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
    Paparella ML, Brandizzi D, Santini-Araujo E, Cabrini RL.
    Histopathology; 2012 Feb; 60(3):514-6. PubMed ID: 22168273
    [No Abstract] [Full Text] [Related]

  • 2. Osteoporosis drugs linked to jawbone destruction.
    J Calif Dent Assoc; 2014 Jul; 42(7):435. PubMed ID: 25076619
    [No Abstract] [Full Text] [Related]

  • 3. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
    Lee JJ, Cheng SJ, Wang YP, Jeng JH, Chiang CP, Kok SH.
    Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
    [Abstract] [Full Text] [Related]

  • 4. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
    Wynn RL.
    Gen Dent; 2011 Jan; 59(5):330-2. PubMed ID: 22313815
    [No Abstract] [Full Text] [Related]

  • 5. [Osteonecrosis of the jaw].
    Drozdzowska B.
    Endokrynol Pol; 2011 Jan; 62 Suppl 3():4-9. PubMed ID: 22161980
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK, Ogle O.
    Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-Related Osteonecrosis of the Jaw in an 80-Year-Old Woman with Diabetes Mellitus: Case Report.
    Valenzuela L, Alonso-Bouzón C, Mañas LR.
    J Am Geriatr Soc; 2015 Oct; 63(10):2221-2. PubMed ID: 26481002
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
    Jimenez-Soriano Y, Bagan JV.
    Med Oral Patol Oral Cir Bucal; 2005 Jul 01; 10 Suppl 2():E88-91. PubMed ID: 15995577
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate.
    Badel T, Pavicin IS, Carek AJ, Rosin-Grget K, Grbesa D.
    Coll Antropol; 2013 Jun 01; 37(2):645-51. PubMed ID: 23941019
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
    Pechalova P, Bakardjiev A, Zaprianov Z, Vladimirov B, Poriazova E, Zheleva A, Hadjigeorgiev G, Goranova-Marinova V, Goranov S.
    Acta Clin Croat; 2011 Jun 01; 50(2):273-9. PubMed ID: 22263396
    [Abstract] [Full Text] [Related]

  • 15. The case of the overlooked osteoclasts.
    Eisenberg S.
    ONS Connect; 2011 Nov 01; 26(11):21. PubMed ID: 22167997
    [No Abstract] [Full Text] [Related]

  • 16. Awareness and education of patients receiving bisphosphonates.
    Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S.
    J Craniomaxillofac Surg; 2012 Apr 01; 40(3):277-82. PubMed ID: 21612939
    [Abstract] [Full Text] [Related]

  • 17. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A.
    Clin Calcium; 2012 Jan 01; 22(1):83-90. PubMed ID: 22201103
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate exposure and osteonecrosis of the jaw.
    Borromeo GL, Brand C, Clement JG, McCullough M, Crighton L, Hepworth G, Wark JD.
    J Bone Miner Res; 2015 Apr 01; 30(4):749-50. PubMed ID: 25808734
    [No Abstract] [Full Text] [Related]

  • 19. Bisphosphonate exposure and osteonecrosis of the jaw.
    Hatton RC, Patel P, Liu W.
    J Bone Miner Res; 2015 Apr 01; 30(4):748. PubMed ID: 25808733
    [No Abstract] [Full Text] [Related]

  • 20. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug 01; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.